Cargando…
A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies
Highly accurate serological tests are key to assessing the prevalence of SARS-CoV-2 antibodies and the level of immunity in the population. This is important to predict the current and future status of the pandemic. With the recent emergence of new and more infectious SARS-CoV-2 variants, assays all...
Autores principales: | Mravinacova, Sara, Jönsson, Malin, Christ, Wanda, Klingström, Jonas, Yousef, Jamil, Hellström, Cecilia, Hedhammar, My, Havervall, Sebastian, Thålin, Charlotte, Pin, Elisa, Tegel, Hanna, Nilsson, Peter, Månberg, Anna, Hober, Sophia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495044/ https://www.ncbi.nlm.nih.gov/pubmed/34628049 http://dx.doi.org/10.1016/j.nbt.2021.10.002 |
Ejemplares similares
-
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
por: Havervall, Sebastian, et al.
Publicado: (2022) -
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19
por: Havervall, Sebastian, et al.
Publicado: (2021) -
Long‐term SARS‐CoV‐2‐specific and cross‐reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
por: Laurén, Ida, et al.
Publicado: (2022) -
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
por: Rudberg, Ann-Sofie, et al.
Publicado: (2020) -
Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time
por: Havervall, Sebastian, et al.
Publicado: (2022)